VOR 250117 7.50C (VOR250117C7500) Stock Options, News & Quotes

US OptionsDetailed Quotes

VOR250117C7500

Watchlist

0.05
0.000.00%

15min DelayTrading Dec 30 11:40 ET

0.05High0.05Low

Intraday

5D
Daily

News

JMP Securities Maintains Vor Biopharma(VOR.US) With Buy Rating, Maintains Target Price $6
Moomoo NewsDec 30 01:32 ET · Ratings
JMP Securities Maintains Vor Biopharma(VOR.US) With Buy Rating, Cuts Target Price to $6
Moomoo NewsDec 27 19:32 ET · Ratings
Analysts Are Bullish on Top Healthcare Stocks: Precigen (PGEN), Vor Biopharma (VOR)
TipRanksDec 27 16:30 ET · Ratings
12 Health Care Stocks Moving In Friday's Pre-Market Session
BenzingaDec 27 16:05 ET
What's Going On With Vor Biopharma Shares Friday?
BenzingaDec 27 13:47 ET
Express News | Vor Biopharma Inc : Wedbush Cuts Target Price to $7 From $11
ReutersDec 27 11:27 ET

Comments

小竜

6 hours ago

$Vor Biopharma (VOR.US)$ Its time.

This_Guy

Dec 29 09:09

$Vor Biopharma (VOR.US)$
Was watching this Friday painting a beautiful chart not sure why I didn't enter but I will likely enter Monday.

小竜

Dec 27 10:50

$Vor Biopharma (VOR.US)$ be quiet 🤫🤫🤫

Jaguar8

Dec 9 06:37

NEWS

$Vor Biopharma (VOR.US)$
Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback from FDA Regarding Registrational Trial Design
• Preliminary data suggests improved relapse-free survival compared to published groups of acute myeloid leukemia (AML) patients at high risk of relapse post-transplant
• Trem-cel + Mylotarg continue to demonstrate engraftment, shielding, and broadened therapeutic window
...

Trytosaveabit

Dec 9 06:31

Update

$Vor Biopharma (VOR.US)$ Reuters· 1 min ago
Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback From FDA Regarding Registrational Trial Design